Randomized, Hybrid Type 1 Effectiveness-implementation Trial of GetActive+ Vs Treatment As Usual; IHOPE Study
The goal of this project is to conduct a randomized, hybrid type 1 effectiveness-implementation trial (N=200) to evaluate the effectiveness and implementation of a 10-week mind-body and walking program (GetActive+) vs treatment as usual (TAU). The investigators will test for improvements in self-reported, performance-based (i.e., six-minute walk test), and objective (i.e., step-count) physical function, emotional function, as well as feasibility, acceptability and implementation markers. Participants will complete measures at baseline (0 weeks), post-intervention (1 week after intervention completion), and 6-month follow-up. This study will receive support from and inclusion in the HEAL Initiative (https://heal.nih.gov/).
• Older Adults (i.e., age \>=55)
• Diagnosed musculoskeletal chronic pain of any type (e.g., pain \> 3 months)
• Pain score \>=4 (moderate) on the Numerical Rating Scale
• Cognitively able to participate as measured by the Short Portable Mental Health questionnaires (e.g., \<4 errors)
• No self-reported current active, untreated psychotic or substance use disorder that would interfere with participation in the research study
• Self-reported ability to complete the 6-minute walk test
• Patient at Revere HealthCare Center or MGH Broadway Primary Care in Revere who is cleared for participation by medical staff
• English fluency or Spanish fluency